- A robust Bayesian dose-finding design for phase I/II clinical trials
- A robust Bayesian mixed effects approach for zero inflated and highly skewed longitudinal count data emanating from the zero inflated discrete Weibull distribution
- Keyboard design for phase I drug-combination trials
- Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials
- Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials
This page was built for software: Keyboard
